Exane Derivatives Sema4 Holdings Corp. Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

A detailed history of Exane Derivatives transactions in Sema4 Holdings Corp. stock. As of the latest transaction made, Exane Derivatives holds 62,153 shares of SMFR stock, worth $21,132. This represents 0.05% of its overall portfolio holdings.

Number of Shares
62,153
Holding current value
$21,132
% of portfolio
0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022
BUY
$1.22 - $3.05 $75,826 - $189,566
62,153 New
62,153 $78,000
Q1 2022

Apr 22, 2022
SELL
$2.64 - $4.67 $164,083 - $290,254
-62,153 Closed
0 $0
Q4 2021

Jan 28, 2022
BUY
$4.4 - $8.8 $89,760 - $179,520
20,400 Added 48.86%
62,153 $277,000
Q3 2021

Oct 26, 2021
BUY
$7.44 - $13.99 $310,642 - $584,124
41,753 New
41,753 $316,000

Others Institutions Holding SMFR

# of Institutions
3
Shares Held
166K
Call Options Held
0
Put Options Held
0
View Full List

About Sema4 Holdings Corp.

SMFR Quotes by TradingView
  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email